Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

BACKGROUND: Presence of disseminated tumor cells (DTCs) in bone marrow (BM) after completion of systemic adjuvant treatment predicts reduced survival in breast cancer. The present study explores the use of DTCs to identify adjuvant insufficiently treated patients to be offered secondary adjuvant tre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Synnestvedt, Marit, Borgen, Elin, Wist, Erik, Wiedswang, Gro, Weyde, Kjetil, Risberg, Terje, Kersten, Christian, Mjaaland, Ingvil, Vindi, Lise, Schirmer, Cecilie, Nesland, Jahn Martin, Naume, Bjørn
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3576235/
https://ncbi.nlm.nih.gov/pubmed/23259667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-616
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars